This guideline covers diagnosing and managing atopic eczema in children under 12. It aims to improve care for children with atopic eczema by making detailed recommendations on treatment and specialist referral. The guideline also explains how healthcare professionals should assess the effect eczema has o...
This guideline covers diagnosing and managing first or recurrent upper or lower urinary tract infections in infants, children and young people. It aims to achieve more consistent clinical practice, based on accurate diagnosis and effective management. This guideline includes recommendations on: investiga...
This guideline covers assessing and managing heavy menstrual bleeding (menorrhagia). It aims to help healthcare professionals investigate the cause of heavy periods that are affecting a woman’s quality of life and to offer the right treatments, taking into account the woman’s priorities and preferenc...
“Self-care is the ability of individuals, families and communities to promote health, prevent disease, and maintain health and to cope with illness and disability with or without the support of a healthcare provider” Current epidemiological evidence indicates four non-communicable diseases (NCDs) mak...
This guideline covers recognising, assessing and treating post-traumatic stress disorder (PTSD) in children, young people and adults. It aims to improve quality of life by reducing symptoms of PTSD such as anxiety, sleep problems and difficulties with concentration. Recommendations also aim to raise awar...
Zinzani, Pier Luigi;
Marchetti, Monia;
Billio, Atto;
Barosi, Giovanni;
Carella, Angelo Michele;
Lazzarino, Mario;
Martelli, Maurizio;
Rambaldi, Alessandro;
Rigacci, Luigi;
Tarella, Corrado;
Vitolo, Umberto;
Tura, Sante.
By using the GRADE system, we updated the guidelines for management of follicular cell lymphoma issuedin 2006 from SIE, SIES, and GITMO group. We confirmed our recommendation to frontline chemoimmuno-therapy in patients with Stage III–IV disease and/or high tumor burden. Maintenance rituximab was alsor...
Anticuerpos Monoclonales,
Anticuerpos,
Anticuerpos Monoclonales de Origen Murino/uso terapéutico,
Antineoplásicos,
Esquema de Medicación,
Trasplante de Células Madre Hematopoyéticas,
Linfoma Folicular/patología,
Linfoma/terapia,
Estadificación de Neoplasias,
Rituximab,
Factores de Tiempo
Bourdel, N;
Huchon, C;
Wahab, C. A;
Azaïs, H;
Bendifallah, S;
Bolze, P. A;
Brun, J. L;
Canlorbe, G;
Chauvet, P;
Chereau, E;
Courbiere, B;
Rouge, T. de L. M;
Devouassoux-Shisheboran, M;
Eymerit-Morin, C;
Fauvet, R;
Gauroy, E;
Gauthier, T;
Grynberg, M;
Koskas, M;
Larouzee, E;
Lecointre, L;
Levêque, J;
Margueritte, F;
Mathieu, E D;
Nyangoh-Timoh, K;
Ouldamer, L;
Raad, J;
Raimond, E;
Ramanah, R;
Rolland, L;
Rousset, P;
Rousset-Jablonski, C;
Thomassin-Naggara, I;
Uzan, C;
Zilliox, M;
Daraï, E.
In the Early Stages (ES) of Borderline Ovarian Tumor (BOT), if surgery without risk of tumor rupture is possible, then laparoscopy with protected extraction is recommended over laparotomy (Grade C). In case of bilateral serous ES BOT treatment with a strategy to preserve fertility and/or endocrine functi...
